S 5682
| Code | Size | Price |
|---|
| TAR-T24749-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
S 5682 is a purified flavonoid fraction composed. S 5682 has anti-oedematous effect anti-inflammatory properties.
CAS:
111804-73-0
Formula:
C56H66O30
Molecular Weight:
1219.114
Purity:
0.98
SMILES:
COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1.COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1
References
1. Di Perri T, Auteri A. Action of S 5682 on the complement system. In vitro and in vivo study. Int Angiol. 1988 Apr-Jun;7(2 Suppl):11-5. PubMed PMID: 3183451.
2. Bouskela E, Svensj? E, Cyrino FZ, Lerond L. Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol. Int J Microcirc Clin Exp. 1997;17 Suppl 1:18-20. PubMed PMID: 9477040.
3. Godfraind T. Effect of a flavonoid preparation (S 5682) on experimental capillary permeability increase in rat paw and rabbit skin. Int Angiol. 1988 Apr-Jun;7(2 Suppl):17-9. PubMed PMID: 3183452.
4. Galley P, Thiollet M. A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility. Int Angiol. 1993 Mar;12(1):69-72. PubMed PMID: 8376915.